Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Immunotherapy treatment of patients with metastatic cancer has assumed a prominent role in the clinic. Durable complete response rates of 20-25% are achieved in patients with metastatic melanoma following adoptive cell transfer of T cells derived from metastatic lesions, responses that appear in som...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Immunol Res
Päätekijät: Prickett, Todd D., Crystal, Jessica S., Cohen, Cyrille J., Pasetto, Anna, Parkhurst, Maria R., Gartner, Jared J., Yao, Xin, Wang, Rong, Gros, Alena, Li, Yong F., El-Gamil, Mona, Trebska-McGowan, Kasia, Rosenberg, Steven A., Robbins, Paul F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4970903/
https://ncbi.nlm.nih.gov/pubmed/27312342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0215
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia